JP2000102378A - High-density bacillus sp and highly concentrated bacillus sp metabolite-including material, and production and utilization thereof - Google Patents

High-density bacillus sp and highly concentrated bacillus sp metabolite-including material, and production and utilization thereof

Info

Publication number
JP2000102378A
JP2000102378A JP10249160A JP24916098A JP2000102378A JP 2000102378 A JP2000102378 A JP 2000102378A JP 10249160 A JP10249160 A JP 10249160A JP 24916098 A JP24916098 A JP 24916098A JP 2000102378 A JP2000102378 A JP 2000102378A
Authority
JP
Japan
Prior art keywords
bacillus
metabolite
density
concentration
metabolites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10249160A
Other languages
Japanese (ja)
Other versions
JP3768694B2 (en
Inventor
Tsutomu Nishimura
勤 西村
Eizo Takagi
栄蔵 高城
Sumiko Takagi
澄子 高城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAKI SEIBUTSU KAGAKU KENKYUSHO
TAKI SEIBUTSU KAGAKU KENKYUSHO KK
Original Assignee
TAKI SEIBUTSU KAGAKU KENKYUSHO
TAKI SEIBUTSU KAGAKU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAKI SEIBUTSU KAGAKU KENKYUSHO, TAKI SEIBUTSU KAGAKU KENKYUSHO KK filed Critical TAKI SEIBUTSU KAGAKU KENKYUSHO
Priority to JP24916098A priority Critical patent/JP3768694B2/en
Publication of JP2000102378A publication Critical patent/JP2000102378A/en
Application granted granted Critical
Publication of JP3768694B2 publication Critical patent/JP3768694B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Treatment Of Biological Wastes In General (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To produce the subject material useful for therapy of infectious diseases of animals (e.g. human beings, livestock or the like) and plants or the like by increasing the concentration of metabolite or products through the repetition of a multiplication cycle consisting of germination, growth, disassembly and sporulation of spores of microorganisms belonging to bacillus genus. SOLUTION: This method for producing a material including high-density Bacillus sp. and highly concentrated Bacillus sp. metabolite is to increase the concentration of metabolite or products secreted from Bacillus sp. due to the activity and/or sporulation of cells through the repetition of a multiplication cycle consisting of germination, growth, disassembly and sporulation of spores of Bacillus sp. and is as follows: (1) multiplication of Bacillus sp. in drainage system such as effluent treatment facility, a culture vessel or the like; (2) collecting the precipitate when the spore concentration of Bacillus sp. in precipitate such as sludge become ca. 108/g and subjecting the precipitate to solid-liquid separation, followed by drying it; (3) imparting nutrient, oxygen and heat to it, followed by fermentation; (4) repeating the above processes to increase the spore density of Bacillus sp. as well as the concentration of its metabolite and products.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、新規な発想によ
り、Bacillus sp の高密度化とその代謝物や生成物質の
高濃度化を図り、更にはBacillus sp の低密度化とその
代謝物や生成物質の高濃度化を図る新規な方法ととも
に、この高濃度化された代謝物や生成物質を用いて、人
や家畜、家禽、魚介類更には農産物などの動植物に対す
る、病原性微生物や病害虫の防疫や伝染性疾病の治療、
抗ウイルス免疫の向上、抗ストレス作用を発現させる方
法、及び土壌中に含まれる農薬類を分解して土壌浄化を
行なう新規な方法に関する。
BACKGROUND OF THE INVENTION The present invention is based on a novel concept to increase the density of Bacillus sp and to increase the concentration of metabolites and products thereof, and further to reduce the density of Bacillus sp and its metabolites and formation Along with a new method to increase the concentration of substances, this increased concentration of metabolites and produced substances is used to control pathogenic microorganisms and pests against animals and plants such as humans, livestock, poultry, seafood, and agricultural products. And treatment of infectious diseases,
The present invention relates to a method for improving antiviral immunity, expressing an antistress effect, and a novel method for decomposing pesticides contained in soil to purify the soil.

【0002】[0002]

【従来の技術】従来から、動植物の防疫や伝染性疾病の
治療、免疫機能の向上に、Bacillus sp や特にその代謝
物(産出物)が有効であることが知られている。この場
合、Bacillus sp 密度やその代謝物濃度は、高い程有効
に利用できる。しかし、従来はBacillus sp 密度や代謝
物濃度が低いため大量の材を必要とし、その利用に大き
な限界があった(従来品は、本発明品の100分の1以
下)。また、代謝物の場合、液中処理のため、常に流出
して高濃度化は不可能であった。本発明では、これを乾
式増殖により行ない成功した。
2. Description of the Related Art It has been known that Bacillus sp and particularly its metabolites (products) are effective in preventing epidemics of animals and plants, treating infectious diseases, and improving immune functions. In this case, the higher the Bacillus sp density and its metabolite concentration, the more effectively it can be used. However, conventionally, a large amount of wood was required due to low Bacillus sp density and metabolite concentration, and there was a great limitation in its use (the conventional product was one hundredth or less of the product of the present invention). In the case of metabolites, because of treatment in a liquid, they always flowed out, making it impossible to increase the concentration. In the present invention, this was successfully achieved by dry propagation.

【0003】また、農業や養殖漁業では、現在その場限
りの生産性追求に追われ、抗生物質や農薬の散布、過剰
栄養の投与、薬漬の栽培が行われている。このような傾
向は世界的にも進行しており、O157のような問題を
惹起する原因ともなっている。また、圃場のマトリック
スから汚れや病原菌を除去するため、培養地の取り替え
と殺菌、殺虫処理、ゼオライト散布によるアンモニアや
アンモニウム塩の吸着除去、焼却消毒、抗生物質の過剰
な投与、ホルモン剤の投与、濾過材による物理的濾過、
等等が実施されているが、何れも多大の費用と労力を要
するものの、常に対象療法に収支しているため、決定的
効果を得ることは困難な状況にある。
[0003] In agriculture and aquaculture, at present, the pursuit of ad hoc productivity is pursued, and the spraying of antibiotics and pesticides, the administration of excess nutrients, and the cultivation of drug pickles are being carried out. Such a tendency is progressing worldwide, and causes a problem like O157. In addition, to remove dirt and pathogens from the matrix of the field, replacement and sterilization of the culture area, insecticide treatment, adsorption removal of ammonia and ammonium salts by spraying zeolite, incineration disinfection, excessive administration of antibiotics, administration of hormones, Physical filtration by filtration media,
Although such methods have been implemented, they all require a great deal of cost and labor, but because they always balance the target treatment, it is difficult to obtain decisive effects.

【0004】[0004]

【発明が解決しようとする課題】そこで本発明者は、第
一の問題に対して、Bacillus sp の特性、機能を調査検
討し、Bacillus sp 胞子の高密度化と代謝物や生成物質
の高濃度化を同時に図る方法を、更には高密度化した胞
子の低密度化とともにさらなる代謝物や生成物質の高濃
度化を図る方法を開発した。
Therefore, the present inventor has studied and studied the characteristics and functions of Bacillus sp for the first problem, and has investigated the densification of Bacillus sp spores and the high concentration of metabolites and produced substances. We have developed a method that simultaneously increases the concentration of metabolites and produced substances as well as a method that simultaneously increases the density of spores that have been increased in density.

【0005】また、第二の問題に対しては、この高濃度
化されたBacillus sp 代謝物や生成物質、或いはその混
在物そのものを、動植物に餌や肥料として与えることに
より、解決する方法を開発した。
[0005] In addition, a method has been developed to solve the second problem by feeding the enriched Bacillus sp metabolites and products, or the mixture itself, as feed or fertilizer to animals and plants. did.

【0006】[0006]

【課題を解決するための手段】Bacillus sp (バチルス
族バクテリア)は、地球上の至る所に生存するが、その
分布密度は極めて低く、通常その密度は103 個/g以
下に止まる。また、生存条件、増殖条件が偶然に整った
限られた場所においても、104 個/g程度に止まって
いる。他方、Bacillus sp の代謝物濃度にあっては、そ
れらの希薄なBacillus sp 相より分泌されたものに止ま
り、極めて低いものの、自然界にあっては病原菌の抑制
や溶菌に働き、健康な自然の維持に働いている。そこ
で、本発明者らは、Bacillus sp の密度を人為的に極め
て高密度化することによって、高濃度化された代謝物や
生成物質を有効に利用し、人や家畜、家禽、魚介類更に
は植物の免疫向上、防疫、伝染性疾患の治療、成長促
進、残留飼料の腐敗防止、或いは土壌の残留農薬の分解
等に役立てることを可能にした。
The Bacillus sp (Bacillus bacterium) survives all over the earth, but its distribution density is extremely low, and its density is usually less than 10 3 / g. In addition, even in a limited place where the survival condition and the growth condition are accidentally set, it is only about 10 4 cells / g. On the other hand, the metabolite concentration of Bacillus sp is limited to those secreted from the dilute Bacillus sp phase, and is extremely low, but in the natural world, it works to control and lyse pathogenic bacteria and maintain healthy nature. Working for. Therefore, the present inventors artificially extremely increased the density of Bacillus sp, thereby effectively utilizing the metabolites and the produced substances having a high concentration, and making humans, livestock, poultry, fish and shellfish, and It can be used for improving plant immunity, preventing epidemics, treating infectious diseases, promoting growth, preventing spoilage of residual feed, and decomposing pesticide residues in soil.

【0007】そこで、本発明者等は自然界よりBacillus
sp を採取し、液体培地中にてBacillus sp の増殖条件
を整えて増殖し、培地中のBacillus sp 密度を108
/ml以上にまで高めることに成功した。このために
は、Bacillus sp を胞子化することが必須条件である。
Bacillus sp の生育や増殖条件は、栄養分の他に適度な
温度と酸素、水分及び炭素源であるが、栄養分を消費し
て培地が貧栄養化すると他の条件が同じでも、Bacillus
sp は胞子化する。次いで、栄養分を与えると発芽し次
第に高密度化する。培地中の菌相は、Bacillus sp の高
密度化と共に、腐敗菌等の嫌気性菌や病原菌、ノカルジ
ア型細菌等も溶菌又は抑制されて、Bacillus sp の優占
化が進行し、Bacillus sp の優占化率は98%を越える
ようになる。尚、この菌相中には、1%程度の酵母菌が
混入していた。Bacillus sp の高密度化は、Bacillus s
p 桿菌を胞子化することによってのみ可能であり、貧栄
養状態と好気的雰囲気、活性化温度の下で胞子化は進行
する。また、排水処理場や屎尿処理場などの汚泥中に
は、元々103 個/g程度のBacillus sp が存在する。
そこで、この汚泥を採取して108 個/g程度まで増殖
してもよいし、排水処理施設等でBacillus sp の増殖に
必要な条件(シリカやマグネシウム分の添加)を与えて
Bacillus sp 密度の高い汚泥を製造してもよい。
Therefore, the present inventors have proposed that Bacillus
The Bacillus sp was collected and grown in a liquid medium under the growth conditions of Bacillus sp. The density of the Bacillus sp in the medium was successfully increased to 10 8 cells / ml or more. For this, sporulation of Bacillus sp is an essential condition.
The growth and growth conditions of Bacillus sp are not only nutrients but also appropriate temperature and oxygen, moisture and carbon sources, but when nutrients are consumed and the medium becomes oligotrophic, Bacillus sp.
sp sporulates. Then, when given nutrients, they germinate and gradually become denser. As the density of Bacillus sp increases, the bacterium in the medium also lyses or suppresses anaerobic bacteria such as spoilage bacteria, pathogenic bacteria, Nocardia-type bacteria, etc., so that Bacillus sp becomes dominant and Bacillus sp becomes dominant. The occupation rate will exceed 98%. In addition, about 1% of yeasts were mixed in this bacterial flora. The densification of Bacillus sp
It is possible only by sporulating p-bacilli, and sporulation proceeds under oligotrophic conditions, aerobic atmosphere, and activation temperatures. In addition, sludge from a wastewater treatment plant or a human waste treatment plant originally contains Bacillus sp of about 10 3 / g.
Therefore, this sludge may be collected and multiplied to about 10 8 / g, or a condition required for the growth of Bacillus sp (addition of silica or magnesium) in a wastewater treatment facility or the like.
Bacillus sp High density sludge may be produced.

【0008】汚泥の場合、次いで胞子化したBacillus s
p の汚泥を分離脱水して、Bacillussp 脱水汚泥(10
8 個/g)を得る。脱水汚泥の含水率は、75〜80%
程度である。更に、脱水汚泥を乾燥(自然乾燥等)して
含水率を55〜65%、Bacillus sp 密度109 個/g
とした後、発酵槽保温箱内に積み上げて発酵させ、Baci
llus sp の糸状体の細胞膜(胞子の脱け殻)や原生動物
の死骸を分解して、高密度Bacillus sp 及び高濃度化さ
れた代謝物含有材を得る。発酵は、乾燥汚泥に空隙材の
役目を併せ持つ栄養源材料や澱粉、糖質、蛋白質、脂
質、水分、酸素、熱を与えて行なう。栄養源材料として
は、例えば大豆粕、コーンフレーク、油粕、その他乾燥
植物チップ等が用いられる。発酵分解が完了すると、胞
子密度、代謝物濃度は共に上昇する。この発酵操作を繰
り返すことにより、胞子密度は1011個/g以上とな
り、代謝物濃度も汚泥中で2%を越えるようになる。
[0008] In the case of sludge, the sporulated Bacillus s
Separately dehydrate the sludge of p, and dehydrate the Bacillussp dehydrated sludge (10
8 / g). The water content of the dewatered sludge is 75-80%
It is about. Further, the dewatered sludge is dried (natural drying, etc.) to have a water content of 55 to 65% and a Bacillus sp density of 10 9 / g.
And fermented by stacking them in a fermenter heat insulation box.
Decompose the cell membrane of the filamentous body of llus sp (the spore husk) and the carcass of the protozoa to obtain a high-density Bacillus sp and a highly concentrated metabolite-containing material. The fermentation is performed by feeding the dried sludge with nutrient materials, starch, saccharides, proteins, lipids, moisture, oxygen, and heat, which also function as a void material. As a nutrient source material, for example, soybean meal, corn flakes, oil cake, and other dried vegetable chips are used. When the fermentation decomposition is completed, both the spore density and the metabolite concentration increase. By repeating this fermentation operation, the spore density becomes 10 11 / g or more, and the metabolite concentration also exceeds 2% in the sludge.

【0009】このように、Bacillus sp の発芽→増殖→
解体→胞子の増殖サイクルを廻せば廻すほどBacillus s
p 密度と代謝物濃度は共に上昇する。もっとも、現在の
ところBacillus sp 密度は1011〜1012個/gが限界
であるが、代謝物や生成物質濃度はさらに増える。ま
た、Bacillus sp の高密度化に従い、病原菌、嫌気性
菌、腐敗菌ノカルジア型細菌等は溶菌乃至抑制され、Ba
cillus sp の優占化が進行し、優占化率も98%を越え
るようになる。
Thus, germination → proliferation → of Bacillus sp
Bacillus s
Both p density and metabolite concentration increase. However, at present, the density of Bacillus sp is limited to 10 11 to 10 12 cells / g, but the concentration of metabolites and produced substances further increases. In addition, as Bacillus sp becomes denser, pathogenic bacteria, anaerobic bacteria, spoilage Nocardia-type bacteria, etc. are lysed or suppressed, and Ba
Dominance of cillus sp progresses, and the dominance rate exceeds 98%.

【0010】尚、本発明で言う代謝物含有材とは、Baci
llus sp の増殖サイクルの結果得られた代謝物や生成物
質を含む、発酵中間物質や発酵残渣物質、バチルスの胞
子や死菌の細胞壁などからなる混合物のことを言う。ま
た代謝物とは、菌体の活動や胞子化、殊に胞子化に伴い
分泌されるものを言い、これには抗生作用を有する環状
ペプチドやいちべのポリペプチドなどが含まれる。生成
物質とは、栄養源の分解物や該分解物同志の反応生成物
例えばアンモニア、硫化水素、アミノ酸、アミノ酸とカ
ルボシル基を有する物質との反応により生じるポリペプ
チドなどが含まれる。そして、代謝物含有材中に含まれ
ているポリペプチドや環状ペプチド等の代謝物や生成物
質は、希エタノールや水等の溶媒に溶出させ、それらの
みを回収して薬剤として利用できる。
The metabolite-containing material referred to in the present invention is Baci
This refers to a mixture of fermentation intermediates and residues, spores of Bacillus and cell walls of dead bacteria, including metabolites and products obtained as a result of the growth cycle of llus sp. The metabolites are those secreted by the activity and sporulation of the bacterial cells, particularly sporulation, and include cyclic peptides and polypeptides having an antibiotic action. The product includes degradation products of nutrients and reaction products of the degradation products, such as ammonia, hydrogen sulfide, amino acids, and polypeptides produced by the reaction of amino acids with substances having a carbosyl group. Then, metabolites and product substances such as polypeptides and cyclic peptides contained in the metabolite-containing material are eluted in a solvent such as dilute ethanol or water, and only these can be recovered and used as drugs.

【0011】尚、本発明の増殖方法は、前記したように
自然界から採取したものや処理場の汚泥を必ずしも出発
原料にする必要はなく、通常はこれら増殖された菌の一
部を種菌として前記同様の工程(サイクル)を繰り返し
行ない、充分な胞子密度にまで増殖させる。
As described above, in the propagation method of the present invention, it is not always necessary to use sludge collected from nature or sludge from a treatment plant as a starting material. The same steps (cycles) are repeated to grow to a sufficient spore density.

【0012】更に、上記した増殖サイクル(栄養増殖サ
イクル)に続けて、貧栄養増殖サイクルを繰り返し行な
うと、代謝物や生成物質濃度をさらに増大させることが
できる。即ち、上記した栄養増殖サイクルによりBacill
us sp 密度が限界或いはそれに近い状態に達したと判断
された場合、続けて貧栄養条件下での発芽を繰り返し行
わせ、消化発酵処理を繰り返えさせる。この場合の貧栄
養化とは、前記した胞子化促進のための貧栄養化とは異
なり、温度と酸素、水分及び炭素源は与えたままで外部
からの栄養の供給を絶ち続けることである。そうする
と、胞子は発芽するが一部は死菌化し他の一部はこの死
菌の細胞壁等を唯一の栄養源として消化する。そして、
Bacillus sp 胞子密度は次第に減少し、自然状態に近い
102 〜104 個/gにまで低下する。このようにする
と、代謝物含有材中の細胞壁等が減少し、相対的に、有
効成分である代謝物や生成物質の濃度が増大する。
Further, when the oligotrophic growth cycle is repeated after the above-described growth cycle (vegetative growth cycle), the concentrations of metabolites and produced substances can be further increased. That is, Bacill by the vegetative growth cycle described above
When it is determined that the us sp density has reached or reached the limit, the germination under oligotrophic conditions is repeated, and the digestion and fermentation treatment is repeated. In this case, the oligotrophic treatment is different from the oligotrophic treatment for promoting spore formation described above, in which the supply of nutrients from the outside is continued while the temperature, oxygen, moisture and carbon source are supplied. Then, the spores will germinate, but some will be killed and the other will be digested using the cell wall of the killed bacteria as the only nutrient. And
Bacillus sp spore density gradually decreases, decreases to 10 2 to 10 4 / g close to natural state. By doing so, the cell walls and the like in the metabolite-containing material decrease, and the concentrations of metabolites and product substances as active ingredients increase relatively.

【0013】尚、バチルス属のバクテリア(Bacillus s
p )は、シリカ、及びマグネシウムが存在すると、胞子
化が大きく促進される。即ち、シリカは有用細菌の細胞
液や細胞膜、胞子膜を構成する重要な物質であり、これ
が不足すると有用細菌の増殖ができなくなる。またマグ
ネシウムは、この有用細菌の世代時間(増殖サイクル)
を極端に短縮させる作用を有している。このシリカ及び
マグネシウム働きは、本発明者らが初めて見いだしたも
のである。尚、温度が高い程増殖速度が早くなる。好ま
しい温度の上限はBacillus sp の種類により異なり、6
2℃或いは45℃程度である。酵母による発酵熱と併せ
てBacillus sp による発酵でり、発酵床全体は45〜6
0℃位まで(副原資材や発酵条件により75℃に達する
場合もある)昇温するため、Bacillus sp の増殖は極め
て早く行なわれる。尚、Bacillussp の活動には更に酸
素が必要になる。酸素の供給は発酵床を攪拌することに
より行なわれるが、頻繁に攪拌すると温度が低下する。
そのため、攪拌は1日1〜2回、数分程度にしておく必
要がある。これらの条件が満たされれば、貪欲に栄養分
を消費して優占化し、他のバクテリア例えばブドウ状球
菌や連鎖状球菌を消滅させる能力を有している。また、
貧栄養状態になれば胞子化し、栄養分の供給で再び発芽
する。
The bacterium belonging to the genus Bacillus (Bacillus s.
p) In the presence of silica and magnesium, sporulation is greatly promoted. That is, silica is an important substance constituting a cell solution, a cell membrane, and a spore membrane of useful bacteria. If this is insufficient, useful bacteria cannot be proliferated. Magnesium is also the generation time of this useful bacterium (growth cycle)
Has an effect of extremely shortening. This function of silica and magnesium was first found by the present inventors. The higher the temperature, the faster the growth rate. The preferred upper limit of the temperature depends on the type of Bacillus sp.
It is about 2 ° C or 45 ° C. Fermentation by Bacillus sp combined with fermentation heat by yeast.
Since the temperature is raised to about 0 ° C. (it may reach 75 ° C. depending on auxiliary raw materials and fermentation conditions), Bacillus sp grows very quickly. In addition, Bacillussp activities require more oxygen. Oxygen is supplied by stirring the fermentation bed, but frequent stirring lowers the temperature.
Therefore, it is necessary to stir once or twice a day for several minutes. If these conditions are met, it has the ability to greedily consume nutrients and become dominant, killing other bacteria such as staphylococci and streptococci. Also,
When they become oligotrophic, they sporulate and germinate again when supplied with nutrients.

【0014】(バチルス属細菌による有機物処理)処理
細菌中には、澱粉や糖質等の炭化水素を分解するもの
と、蛋白質、脂質を分解するものがあり、それらの菌種
毎に胞子形成能にも違いがあるものの、与えられた栄養
の分解に際し常に安定した処理が行なわれておれば、よ
り効果的な菌が優占化するようになる。例えば、流入汚
水のBODが常に12,000ppm を越える処理場におい
てバチルスを高濃度に優占化して極めて良好な処理を行
なっているところの汚泥水について、希釈培養してバチ
ルスの濃度を調べたところ、常に5×108 個/ml〜
5×1010個/mlの密度を示した。
(Organic matter treatment by Bacillus bacterium) Some of the treated bacteria degrade hydrocarbons such as starch and carbohydrates, while others degrade proteins and lipids. Although there is also a difference, if stable treatment is always carried out when decomposing given nutrients, more effective bacteria will become dominant. For example, the sludge water in which Bacillus is dominating to a high concentration and performing very good treatment in a treatment plant where the BOD of the inflowing sewage always exceeds 12,000 ppm was subjected to dilution cultivation to examine the Bacillus concentration. , Always 5 × 10 8 / ml ~
The density was 5 × 10 10 cells / ml.

【0015】(マグネシウム)バチルスを優占化させる
ためには、先ずバチルスの増殖速度に関わる世代時間を
短縮させねばならないが、マグネシウムイオンを供給す
ることによりその目的を達することができる。マグネシ
ウムイオンの供給は必ずしもイオンで供給する必要はな
く、マグネシウム化合物や含有物を発酵床に混入させ、
徐々に溶解するマグネシウムによっても、その目的を達
することができる。但し、バチルス属の中でも種によっ
て、世代時間は様々である。そして、世代時間の短い種
が結果的に優先化していく。
In order to make (magnesium) Bacillus dominant, the generation time related to the growth rate of Bacillus must first be shortened, but the purpose can be achieved by supplying magnesium ions. It is not always necessary to supply magnesium ions with ions, but magnesium compounds and contents are mixed into the fermentation bed,
The purpose can also be achieved by slowly melting magnesium. However, the generation time varies depending on the species of the genus Bacillus. Then, seeds with a short generation time are given priority as a result.

【0016】(シリカ)次いで、増殖したバチルスを高
濃度化するためには、世代時間を終わったバチルスを再
胞子化して温存することが必要である。通常、バチルス
は栄養と水分、酸素、熱の供給を受けて成長して糸状体
を形成し、貧栄養状態に至って内胞子を形成して解体し
て胞子化し、生命を維持するが、準安定型ケイ酸塩鉱物
や珪酸イオン、シラノール存在下で特に顕著にその傾向
を示し、極めて高い胞子化を示す。
(Silica) Next, in order to increase the concentration of the grown Bacillus, it is necessary to respore-form the Bacillus after the generation time and preserve it. Normally, Bacillus grows under the supply of nutrients, water, oxygen, and heat to form filamentous bodies, reaches oligotrophic conditions, forms endospores, dissociates and spores, and sustains life, but is metastable. This tendency is particularly remarkable in the presence of type silicate minerals, silicate ions, and silanols, and shows extremely high sporulation.

【0017】[0017]

【実施例】(実施例1:代謝物含有材の製造)脱水汚泥
1000Kgをコンクリートスラブ上に広げて自然乾燥
し、水分60%程度としたのち、1発酵毎に栄養分とし
て、 グルコース 10Kg スキムミルク 10Kg ミンチ肉 10Kg コーンフレーク 10Kg 食塩 3Kg を加え、更に含水率が65%になるように水を加えて調
整した。発酵中の酸素供給と水分補給は、3日に1回の
割合で行なう切り返しにより行なった。尚、添加栄養分
は上記に限定されるものではない。また、その他溶解シ
リカ分を10ppm程度以上加えることにより、菌体密度
と代謝物濃度の上昇が加速された。 1次発酵処理日数 42日間 2次発酵処理日数 28日間
EXAMPLES (Example 1: Production of a metabolite-containing material) 1000 kg of dehydrated sludge is spread on a concrete slab and air-dried to a water content of about 60%. As a nutrient for each fermentation, glucose 10 kg skim milk 10 kg mince 10 kg of meat 10 kg of corn flakes 3 kg of salt were added, and water was further added so that the water content became 65%. Oxygen supply and hydration during fermentation were performed by turning over once every three days. The added nutrients are not limited to the above. Further, by adding about 10 ppm or more of dissolved silica, the increase in the cell density and the metabolite concentration was accelerated. Primary fermentation treatment days 42 days Secondary fermentation treatment days 28 days

【0018】Bacillus sp 密度は平面培地による希釈培
養法により定量し、Bacillus sp 代謝物や生成物質濃度
の測定は、代表サンプル10.0gを秤量分取し、純水5
00mlを加えて超音波槽(50Kz)で3分間溶出さ
せた後、ニュークリポアフイルター又はGF−Fフイル
ター(0.7μm)で吸引濾過し、105℃の恒温槽内に
恒量として秤量して、溶出前後の重量差により代謝物・
生成物質量を求めた。結果は、以下の通りである。 脱水乾燥汚泥 Bacillus sp 密度 12×108 個/g (比較材) 代謝物% 0.12% 色 黒色 一次発酵処理 Bacillus sp 密度 16×109 個/g 代謝物% 1.34% 色 灰色 二次発酵処理 Bacillus sp 密度 8×1011個/g 代謝物% 2.44% 色 白色 (加水すると代謝物が溶解して黒色になる) 三次発酵処理 Bacillus sp 密度 5×106 個/g 代謝物% 8.03% 消化発酵処理 Bacillus sp 密度 7×103 個/g 代謝物% 11.36% 処理を重ねると代謝物濃度は更に高くなる。このよう
に、比較材(脱水乾燥汚泥)に比較して、Bacillus sp
密度、代謝物濃度共に処理の進行に連れて上昇してい
る。Bacillus sp 密度は限界が予測される(1011〜1
12個/g程度)ものの、代謝物濃度については、更な
る上昇を図ることができる。また、目的により、その密
度を減じたり、無菌化とともに発酵残渣や細胞壁片等を
除去して、ポリペプチドや環状ペプチド等、代謝物や生
成物質による人間や動植物の防疫、伝染製疾病の治療、
免疫の向上、抗ストレス作用の向上等の目的を達するも
のである。従って、高密度Bacillus sp 及び高濃度Baci
llus sp 代謝物を直接利用してその目的を達する範囲も
広くなり、また代謝物を工業的に抽出する場合の基礎工
程、素材としても、極めて有効なものである。尚、代謝
物含有材の製造については、本実施例に限定されるもの
ではない。
The Bacillus sp density was determined by a dilution culture method using a flat medium, and the concentration of Bacillus sp metabolites and produced substances was measured by weighing out and weighing 10.0 g of a representative sample.
After adding 00 ml and eluting in an ultrasonic bath (50 Kz) for 3 minutes, the solution was suction-filtered with a Nuclepore filter or a GF-F filter (0.7 μm), weighed as a constant weight in a 105 ° C. constant temperature bath, and eluted. Metabolites due to weight difference before and after
The amount of product was determined. The results are as follows. Dehydrated and dried sludge Bacillus sp Density 12 × 10 8 / g (Comparative material) Metabolite% 0.12% Color Black Primary fermentation treatment Bacillus sp Density 16 × 10 9 / g Metabolite% 1.34% Color Gray Secondary Fermentation treatment Bacillus sp Density 8 × 10 11 / g Metabolite% 2.44% Color White (The metabolite dissolves and becomes black when hydrated) Tertiary fermentation treatment Bacillus sp Density 5 × 10 6 / g Metabolite% 8.03% digestion and fermentation treatment Bacillus sp Density 7 × 10 3 cells / g Metabolite% 11.36% Repeated treatment increases the metabolite concentration. Thus, compared to the comparative material (dewatered and dried sludge), Bacillus sp.
Both the density and the metabolite concentration increase as the treatment progresses. Bacillus sp density is expected to be limited (10 11 -1
0 about 12 / g) but, for the metabolite concentration, it is possible to further increase. Also, depending on the purpose, reduce its density or remove aseptic fermentation residues and cell wall fragments with sterilization, such as polypeptides and cyclic peptides, metabolites and metabolites and products to prevent epidemics of humans and animals and plants, treatment of infectious diseases,
It achieves the objectives of improving immunity and anti-stress effect. Therefore, high-density Bacillus sp and high-concentration Baci
The use of llus sp metabolites directly to achieve their purpose is widened, and they are also extremely effective as a basic process and material for industrially extracting metabolites. The production of the metabolite-containing material is not limited to this example.

【0019】(ポリペプチドや環状ペプチド等、代謝物
や生成物質濃度の推移)本発明の薬剤製造工程の初期、
中期、終末期、完結期におけるポリペプチドや環状ペプ
チド等、代謝物や生成物質が、それぞれの発酵残渣中に
含有されている。このポリペプチドや環状ペプチド等、
代謝物や生成物質含有量の推移を調査するため、一次工
程終了、二次工程終了、三次工程終了、消化発酵工程終
了、の各時点でサンプリングを行い、それぞれ、10g
を秤量分取し、これに希エタノール(1:3)50ml
を加えて超音波(50kHx、10分)溶解する。次い
で、GF−F(0.7μm)で濾過洗浄して、発酵残渣を
取り除き、溶解液とGF−Fを通過するBacillus sp 胞
子及び細胞壁を得る。この混合液を、それぞれスライド
ガラス上に0.1mlの2点を採取し、クリーン・ベンチ
内で常温乾燥して溶出物質を析出させる。この析出物質
を顕微鏡により観察した。また、他の1点には、無菌水
1滴を滴下して析出物を溶解し、顕微鏡観察した。その
結果、 一次工程では 残留胞子密度は高い 107 個/g 細胞壁片 多い 析出物質 少ない 二次工程では 残留胞子密度は低下 105 個/g 細胞壁片 減少 析出物質 増加 新生成物 出現 三次工程では 残留胞子密度は低下 103 個/g 細胞壁片 消滅 析出物質 増加 新生成物 成長 消化発酵工程では 残留胞子密度は低下 102 個/g 細胞壁片 消滅 析出物質 更に増加 新生成物 更に成長
(Changes in Concentrations of Metabolites and Produced Substances such as Polypeptides and Cyclic Peptides) At the beginning of the drug production process of the present invention,
Metabolites and product substances such as polypeptides and cyclic peptides in the middle stage, terminal stage, and final stage are contained in each fermentation residue. Such as polypeptides and cyclic peptides,
In order to investigate changes in metabolites and product content, sampling was performed at each time point of the end of the primary process, the end of the secondary process, the end of the tertiary process, and the end of the digestive fermentation process, and 10 g each
Weighed and weighed, and diluted ethanol (1: 3) 50 ml
And ultrasonically dissolve (50 kHz × 10 minutes). Then, it is filtered and washed with GF-F (0.7 μm) to remove the fermentation residue, thereby obtaining a lysate, Bacillus sp spores passing through GF-F, and a cell wall. Two 0.1 ml portions of this mixed solution are collected on a slide glass and dried at room temperature in a clean bench to precipitate eluted substances. This deposited substance was observed with a microscope. At one other point, one drop of sterile water was dropped to dissolve the precipitate, and observed under a microscope. As a result, the residual at the primary residual spore density in step higher 10 7 / g cell wall pieces often deposited material remaining spore density was less secondary step reduction 10 5 / g cell wall pieces decreases precipitated substance increasing new product appeared tertiary step Spore density decreases 10 3 / g Cell wall fragment disappears Precipitate increase New product growth Residual spore density decreases in digestion and fermentation process 10 2 / g Cell wall fragment disappears Precipitate further increases New product further grows

【0020】次いで、溶出液全体を蒸発皿に移し入れ
て、低温で蒸発乾固し、デシケーター内で24時間以上
保持して乾燥し、回収された析出物(ポリペプチドや環
状ペプチド等の代謝物)を秤量して、各工程サンプル中
のポリペプチドや環状ペプチド等の代謝物や生成物質の
含有率を求めた。その結果、 一次工程サンプル 6.90% 二次工程サンプル 8.30% 三次工程サンプル 10.36% リサイクルサンプル 11.41% であった。この結果は、先の顕微鏡観察結果と一致する
挙動であり、このように、増殖→滅菌→消化→増殖、或
いは、増殖→滅菌→消化→発芽→滅菌→消化のサイクル
を繰り返すことにより、ポリペプチドや環状ペプチド等
の代謝物や生成物質の高濃度化とBacillus sp 胞子密度
を低下させたり、残留する細胞壁(ペプチドグリカン+
蛋白質)を消滅させることが明らかとなった。(クリス
タルは消滅し、単糖(ブドウ糖)化している)。
Next, the whole eluate is transferred to an evaporating dish, evaporated to dryness at a low temperature, kept in a desiccator for at least 24 hours and dried, and the collected precipitates (metabolites such as polypeptides and cyclic peptides) are removed. ) Was weighed to determine the content of metabolites and product substances such as polypeptides and cyclic peptides in each process sample. As a result, the primary process sample was 6.90%, the secondary process sample was 8.30%, the tertiary process sample was 10.36%, and the recycled sample was 11.41%. This result is a behavior consistent with the previous microscopic observation results. Thus, by repeating the cycle of proliferation → sterilization → digestion → proliferation, or proliferation → sterilization → digestion → germination → sterilization → digestion, the polypeptide was obtained. Concentration of metabolites and products such as liposomes and cyclic peptides and decrease the spore density of Bacillus sp.
Protein). (Crystals have disappeared and become monosaccharides (glucose).)

【0021】(実施例 2 車海老の養殖)日本国内外
を問わず、車海老その他の海老類の養殖場においては、
海老の伝染病の発生により、たびたび飼育苗が全滅する
被害が発生していることは、周知の事実である。そこ
で、伝染性病気の発生により壊滅的打撃を受けた海老養
殖池(面積10万m2 )の底質を採取し、Bacillus sp
或いはその代謝物によりそれらの病原性微生物を消滅で
きないか、無菌培養槽内で培養テストし、その有効なこ
とを確認した。かかる現象は、Bacillus sp が直接的に
微生物を攻撃したり、環状ペプチドやポリペプチド等の
代謝物や生成物質を放出して相乗的に病原性微生物を消
滅させた結果と言える。そこで、養殖苗に直接、Bacill
us sp やその代謝物、生成物質を供与するため、飼料に
配合して与えた。
(Example 2) Culture of Prawns Prawns and other shrimp farms in Japan and abroad
It is a well-known fact that shrimp infectious diseases often cause the loss of reared seedlings. Therefore, the sediment of a shrimp culture pond (area 100,000 m 2 ) that was devastatingly hit by the outbreak of infectious diseases was collected, and Bacillus sp.
Alternatively, a culture test was carried out in a sterile culture tank to confirm that the pathogenic microorganisms could not be eliminated by the metabolites, and the effectiveness was confirmed. Such a phenomenon can be said to be the result of Bacillus sp directly attacking microorganisms or synergistically eliminating pathogenic microorganisms by releasing metabolites and products such as cyclic peptides and polypeptides. Therefore, Bacill is directly applied to the cultured seedlings.
In order to supply us sp, its metabolites, and products, it was given in feed.

【0022】魚粉、海草粉末、クレー粉末、澱粉を主と
する飼料に、106 〜107 個/gのBacillus sp 代謝
物含有材を5〜10ppm 程度混入した養殖用飼料を作製
して養殖池に散布した。また、この飼料に対して車海老
はよく反応し、順調に馴化した。この実験を通して、通
常、動物や魚介類の防疫に当たっては、体重1kg当た
り1〜100mg、殊に5〜20mg/日の摂取で、十
分その効果を発現できることも、併せて判明した。その
結果、養殖海老苗が全滅する被害は全く無くなり、海老
の生育もよくなり、約2カ月のライフ短縮と大きな歩留
りの向上があった(約8%)。また、底質中の病原性微
生物は3×102 個/g、Bacillus sp密度は15×1
8 個/gと底質が改善されていた。
The fish meal, seaweed powder, clay powder, to feed consisting mainly of starch, 10 6 to 10 7 cells / g of Bacillus sp metabolites containing material to produce aquaculture feed for mixed about 5~10ppm ponds Sprayed. The prawns responded well to this feed, and they became well adapted. Through this experiment, it was also found that, in the case of epidemics of animals and fish and shellfish, an effect of 1 to 100 mg / kg, particularly 5 to 20 mg / kg / day of body weight can sufficiently exert its effects. As a result, the shrimp shrimp seedlings were completely eliminated, the shrimp growth was improved, the life was shortened by about 2 months, and the yield was greatly improved (about 8%). The pathogenic microorganism in the sediment was 3 × 10 2 cells / g, and the density of Bacillus sp was 15 × 1.
0 8 / g and the sediment has been improved.

【0023】(実施例 3 海老のPRDVウイルスに
対する免疫の向上 )Bacillus sp の代謝物含有材或い
は代謝物・生成物質が、生物の免疫機能を向上させ、ま
たは病原ウイルスを抑制する傾向が見られたので、下記
の実験を行ない、良好な結果を得た。即ち、ウイルス性
疾患により車海老が全滅した養殖池の底質30リットル
を採り、これに車海老苗を投入し2日間養生して鰓に急
性ウイルス血症(PRDV)のウイルスを付着させた。
次いで、ウイルス感染海老苗を二分割し、一方には通常
の餌を与えた。他方には、通常の餌にBacillus sp 10
11個/g及びその代謝物を1%混入した餌を作成し、養
殖海老重量1Kg当たりBacillus sp 及びその代謝物を
10mg/日となるように与えた。その結果、図1に示
すように、通常の餌の水準では3日間で全滅したが、Ba
cillus sp 及び代謝物混入餌の場合には、5日間で消耗
率25%、10日間で30%、20日では31%であ
り、抗ウイルス免疫が大きく向上していた。従って、平
常より適宜かかるBacillus sp 代謝物含有材配合の餌を
投与することにより、養殖海老の歩留りを大きく向上で
きることが判明した。
Example 3 Improving Immunity of Shrimp to PRDV Virus Bacillus sp metabolite-containing materials or metabolites / producers tend to improve the immune function of organisms or suppress pathogenic viruses. Therefore, the following experiment was performed, and good results were obtained. That is, 30 liters of bottom sediment of a culture pond in which prawns were completely destroyed due to a viral disease were taken, prawn seedlings were put into the ponds, and the prawns were cured for 2 days to attach acute viremia (PRDV) virus to the gills.
The virus-infected shrimp seedlings were then split in two, one fed normal diet. On the other hand, Bacillus sp.
A diet containing 11 g / g and its metabolite in 1% was prepared and fed with Bacillus sp and its metabolite at 10 mg / day per 1 kg of cultured shrimp. As a result, as shown in FIG.
In the case of cillus sp and the metabolite-containing diet, the depletion rate was 25% for 5 days, 30% for 10 days, and 31% for 20 days, indicating that the antiviral immunity was significantly improved. Therefore, it was revealed that the yield of cultured shrimp can be significantly improved by administering such a bait containing the Bacillus sp metabolite-containing material as appropriate.

【0024】(実施例 4 Bacillus sp 代謝物や生成
物質による免疫の向上:鶏、豚)既に、大規模養鶏場に
おいて発生した集団的鶏の伝染性下痢を、Bacillus sp
代謝物を飲用水としてあたえて、3日間で根治した事例
を、『畜舎の悪臭防止と腐敗菌の抑制システムと設備:
特願平7−276461号』で明らかにした。その後、
当該養鶏場では全く薬物を与えることなく、上記の飲用
水を与えるのみで、鶏の病気が発生しなくなった。ま
た、養豚場においても、飼料にBacillus sp1011個/
gと代謝物を体重の0.001%相当量を混入して与えた
ところ、同様の効果が認められた。これらの現象は、特
にポリペプチドや環状ペプチドをはじめとする代謝物や
生成物質の微量を与えることによる豚の免疫が著しく向
上した結果と考えられる。最近では、哺乳動物以外の生
物、特に魚介類特に海老やシャコ、バチネラ等に生成物
質の微量を与えることにより、ビールス性の病気を予防
できることが実験的に確かめられているが、その他の動
物の免疫も向上する働きがあると考えられる。
(Example 4 Enhancement of Immunity by Bacillus sp Metabolite and Product: Chicken, Pig) Infectious diarrhea of a collective chicken that has already occurred in a large-scale poultry
A metabolite was given as drinking water and cured in three days.
Japanese Patent Application No. 7-276461. afterwards,
At the poultry farm, chicken water was not given at all and only the above drinking water was given without giving any drug. Also, in pig farms, Bacillus sp10 11 /
When g and metabolites were given in a mixed amount of 0.001% of the body weight, the same effect was observed. These phenomena are considered to be the result of the marked improvement in immunity of pigs, especially by giving trace amounts of metabolites and produced substances including polypeptides and cyclic peptides. Recently, it has been experimentally confirmed that by providing a small amount of a produced substance to organisms other than mammals, particularly to fish and shellfish, particularly shrimp, sharks, and bachinella, it is possible to prevent viral diseases. It is thought that immunity is also improved.

【0025】(実施例 5 ポリペプチドや環状ペプチ
ド等代謝物や生成物質による鶏の病気予防と治療)本発
明のポリペプチドや環状ペプチド等代謝物や生成物質よ
りなる薬剤による鶏の病気予防や治療について実験し
た。実験区の鶏舎の鶏1200羽に対し本発明の薬剤0.
01%を含有する飲料水を投与し続けた。また、対照区
の鶏舎の鶏1000羽に対しては、通常の水道水を飲料
水として与えた。実験より39日目(6月10日)に至
って、対照区では下痢が発生し、その3日後には、対照
区全般に拡がった。直ちに、市販の抗生物質入りの飼料
の投与に切り換えたが下痢は収束せず、更に異種の抗生
物質入りの飼料に切り換えてみても効果が無かった。
Example 5 Prevention and Treatment of Chicken Diseases by Metabolites and Products such as Polypeptides and Cyclic Peptides Prevention and Treatment of Chicken Diseases by Drugs of the Present Invention Containing Metabolites and Products such as Polypeptides and Cyclic Peptides Was tested. The drug of the present invention was added to 1200 chickens in the poultry house in the experimental plot.
Drinking water containing 01% was continued to be administered. In addition, ordinary tap water was given as drinking water to 1,000 chickens in the poultry house in the control plot. On the 39th day (June 10) from the experiment, diarrhea occurred in the control group, and after 3 days, it spread to the entire control group. Immediately, the administration was switched to a diet containing a commercially available antibiotic, but diarrhea did not converge, and switching to a diet containing a different type of antibiotic had no effect.

【0026】この時点において、実験区では下痢の発生
が無く、鶏の健康状態もよいことから、対照区にも本発
明の薬剤0.01%を含有する飲料水をタンクに造りお
き、給水管により給水を開始した。給水開始より2日後
には、大部分の鶏の下痢は止まり、3日目には鶏舎全体
が治癒した。その後、この給水を継続したところ、集団
性の下痢は発生しなくなった。尚、下痢便について培養
検査したところ、サルモネラ菌が検出された。実験区で
は検出されなかった。この結果より、Bacillus sp 胞子
や細胞壁(ペプチドグリカンや蛋白質)を全く含まない
ポリペプチドや環状ペプチド等代謝物や生成物質によ
り、鶏の伝染性疾病の予防と治療、免疫の向上が得られ
ることが明らかとなった。
At this time, since no diarrhea occurred in the experimental plot and the chickens were in good health, drinking water containing 0.01% of the drug of the present invention was also prepared in the control plot, and the water supply pipe was provided. Started water supply. Two days after the start of watering, most chickens had diarrhea, and on the third day the whole house was cured. Thereafter, when this water supply was continued, no collective diarrhea occurred. In addition, when the diarrhea stool was cultured and examined, Salmonella was detected. It was not detected in the experimental plot. From these results, it is clear that metabolites and products such as polypeptides and cyclic peptides containing no Bacillus sp spores or cell walls (peptidoglycan or protein) can prevent, treat, and improve immunity of chickens' infectious diseases. It became.

【0027】(実施例 6 豚の防疫)平均体重12K
gの子豚10頭×2実験区と、10頭の対照区を用意
し、各実験区には本発明のポリペプチドや環状ペプチド
等代謝物や生成物質よりなる薬剤(消化発酵処理→遠心
分離)を混入した飼料を投与し、対照区には、薬剤を混
入しない餌を投与し、60日間飼育した。実験区におけ
る薬剤混入水準は、実験1区では体重1kg当たり0.5
mg、実験2区では同じく1.0mgである。 No. 代謝物等水準 類型発病数 備考 実験1区 0.5mg 0 実験2区 1.0mg 0 対照区 0mg 6 抗生物質投与 この結果、実験区では何らの病気も発生しなかったが、
対照区では腸ビブルス菌による下痢が発生した。これ
は、本発明のポリペプチドや環状ペプチド等代謝物や生
成物質よりなる薬剤が、子豚の免疫向上や伝染性疾病の
予防に効果があることを示す。
Example 6 Protection of Pigs Average Weight 12K
g piglets × 10 experimental pigs and 10 control pigs were prepared, and in each experimental plot, a drug (digestion / fermentation → centrifugation) consisting of a metabolite or product such as the polypeptide or cyclic peptide of the present invention was prepared. ) Was administered, and a control group was administered a diet containing no drug, and bred for 60 days. The level of drug contamination in the experimental plot was 0.5 per kg of body weight in the experimental plot.
mg, and 1.0 mg in the experimental two sections. No. Level of metabolites, etc. Type of incidence Remarks Experiment 1 group 0.5 mg 0 Experiment 2 group 1.0 mg 0 Control group 0 mg 6 Antibiotic administration As a result, no disease occurred in the experimental group.
In the control group, diarrhea caused by intestinal vibrios occurred. This indicates that a drug comprising a metabolite or a product such as the polypeptide or cyclic peptide of the present invention is effective for improving immunity of piglets and preventing infectious diseases.

【0028】(実施例 7 免疫賦活・NK活性賦活)
痛みを訴える末期の癌患者(85才女性)に、代謝物含
有材2gを蒸留水500ccに溶解した上澄み液を毎日
飲用させたところ、1日目から痛みが和らぎ、1週間経
過したころから全く痛みを感じなくなった。
(Example 7: Immunostimulation / NK activation)
A terminal cancer patient (85-year-old woman) who complained of pain was allowed to drink a supernatant liquid obtained by dissolving 2 g of a metabolite-containing material in 500 cc of distilled water every day. I no longer feel pain.

【0029】一方、57才の健康な男性について、癌細
胞を攻撃すると言われるナチュラルキラー細胞の活性
(NK活性)の測定値(三菱化学で測定)が、通常10
〜20であったものが、本発明の代謝物含有材を1日1
gを3日間飲用したのち測定したところ、60になっ
た。通常、このような高い値は(特に三菱化学測定の場
合)考えられないことである。
On the other hand, for a healthy male at the age of 57, the measured value of natural killer cell activity (NK activity) which is said to attack cancer cells (measured by Mitsubishi Chemical) is usually 10%.
-20, the amount of the metabolite-containing material of the present invention was 1
g was measured after drinking for 3 days and found to be 60. Normally, such high values (especially in the case of Mitsubishi Chemical measurements) are unthinkable.

【0030】(実施例 8 リュウマチ治療)長年手指
のリュウマチに悩んでいる60才の女性が、本発明の代
謝物含有材の500mg/日を、1ケ月続けて飲用した
ところ、痛みが完全に消失した。
(Example 8 treatment of rheumatism) When a 60-year-old woman who has been suffering from rheumatoid arthritis for many years has consumed 500 mg / day of the metabolite-containing material of the present invention for one month continuously, the pain completely disappeared. did.

【0031】(実施例 7 水虫、虫刺され、アトピー
性皮膚炎の治療)代謝物含有材2gを蒸留水500cc
に溶解した上澄み液を、足の水虫に毎夕塗布したとこ
ろ、7日後に赤みと痒みが完全に消滅した。その後、再
発はしていない。また、蚊に刺された箇所が腫れる体質
の老人が、この上澄み液を塗布したところ、腫れは全く
みられず、痒みも感じなかった。
Example 7 Treatment of athlete's foot, insect bites, atopic dermatitis 2 g of a metabolite-containing material was added to 500 cc of distilled water.
Was applied to the athlete's foot each evening, and after 7 days, the redness and itch disappeared completely. Since then, there has been no recurrence. An old man with a constitution in which a mosquito bite was swollen showed no swelling and no itching when the supernatant was applied.

【0032】本発明者らは、発熱を伴う激しい下痢や口
内炎、歯肉炎、流行性感冒、気管支炎、アレルギー性皮
膚炎、床擦れによる皮膚炎等に対して、体重の0.001
〜0.0001%相当のBacillus sp 及び代謝物を飲用又
は塗布することにより、これらの症状を速やかに改善乃
至消滅させた経験を共有している。また、皮膚炎等によ
り破壊されたり、損傷を受けた人体細胞が上記処置を施
すことにより、速やかに健康な細胞として復元すること
は、本発明の代謝物や生成物質が人体活性を高めてその
免疫を向上した結果と考えられる。
The present inventors have determined that the body weight of 0.001 against severe diarrhea with fever, stomatitis, gingivitis, epidemic cold, bronchitis, allergic dermatitis, dermatitis due to floor rubbing, and the like.
They share the experience of quickly improving or eliminating these symptoms by drinking or applying Bacillus sp and metabolites equivalent to 0.0001%. In addition, the human body cells destroyed or damaged by dermatitis or the like can be promptly restored as healthy cells by performing the above-mentioned treatment, because the metabolites and produced substances of the present invention enhance the human body activity, This is considered to be the result of improving immunity.

【0033】(実施例 8 化粧品)本発明の粉状薬剤
100mgを、蒸留水800mlに溶解して基液とす
る。これに、エチルアルコール100ml:及びグリセ
リン20gを溶解し、更に、モノマーシリカ(鉱滓を酸
溶解して生成した物質)0.6gを添加混合する。更に、
必要であれば香料を添加する。この化粧品を1ケ月毎日
使用したところ、肌がスベスベして艶がよくなり、小じ
わも解消した。
Example 8 Cosmetics 100 mg of the powdered drug of the present invention is dissolved in 800 ml of distilled water to prepare a base solution. Into this, 100 ml of ethyl alcohol and 20 g of glycerin are dissolved, and 0.6 g of monomer silica (a substance produced by dissolving slag in acid) is further added and mixed. Furthermore,
Add fragrance if necessary. When this cosmetic was used daily for one month, the skin became smooth and glossy, and fine lines were eliminated.

【0034】(実施例 9 抗菌性の確認)寒天平面培
地(澱粉1.5%、ニュートリエント・ブロス0.8%、食
塩0.5%)に、大腸菌、海老養殖場の底質から抽出
したバクテリア、キャベツ畑土壌から抽出したバクテ
リアを植菌し、更に、それぞれ(A)Bacillus sp +代
謝物、(B)Bacillus sp 代謝物含有水、(C)無処理
(比較水準)の各サンプルを作製し、32℃の無菌培養
箱内で72時間培養した。その結果、大腸菌は、A、
Bの各水準で消滅し、C水準では108 個/gを検出し
た。海老養殖場底質は、A水準では黄色葡萄状球菌、
大腸菌、連鎖状球菌は消滅し、Bacillus sp のみ増殖し
た。B水準では、黄色葡萄状球菌、大腸菌、連鎖状球菌
は抑制され、Bacillus sp が発芽した。また、C水準で
は、上記各病原菌が増殖した。キャベツ畑土壌は、
A、B水準では根瘤菌、放線菌が抑制され、Bacillus s
p が増殖した。またC水準では、根瘤菌、放線菌が増殖
し、Bacillus sp は103 個/gに止まった。上記の結
果から、Bacillus sp 及びその代謝物には抗菌作用があ
ることが明らかである。
Example 9 Confirmation of antibacterial activity Escherichia coli was extracted from an agar plate medium (starch 1.5%, nutrient broth 0.8%, salt 0.5%) from the sediment of a shrimp farm. Bacteria and bacteria extracted from cabbage field soil are inoculated, and each sample is prepared for (A) Bacillus sp + metabolite, (B) water containing Bacillus sp metabolite, and (C) untreated (comparative level) Then, the cells were cultured in a sterile culture box at 32 ° C. for 72 hours. As a result, E. coli is A,
Disappeared in each level of B, were detected 10 8 / g at C levels. Shrimp farm bottom sediment is Staphylococcus aureus at A level,
E. coli and streptococci disappeared, and only Bacillus sp grew. At the B level, Staphylococcus aureus, Escherichia coli and Streptococcus were suppressed, and Bacillus sp germinated. At the C level, each of the above pathogenic bacteria grew. Cabbage field soil
At the A and B levels, rhizobia and actinomycetes are suppressed, and Bacillus s
p grew. At the C level, rhizobia and actinomycetes grew, and Bacillus sp remained at only 10 3 / g. From the above results, it is clear that Bacillus sp and its metabolites have an antibacterial effect.

【0035】(実施例 10 残留農薬の分解と地力回
復)最近、あるゴルフ場において、間違って除草剤を散
布し、グリーンの芝が壊滅的な打撃を受け、回復不可能
な状態になった。そこで、グリーンに散布された除草剤
の同一濃度の溶液を入手し、この溶液中の除草剤をBaci
llus sp によって分解できないかを確認テストし、その
可能性を確認できたので、以下の方法で救済処置をとっ
た。Bacillus sp 胞子及びその代謝物を微量に含有する
水を定期的にグリーンに散布してグリーンに残留する除
草剤を分解することとした。 散布する頻度 3日毎に散布 散布量 100リットル/1アール 散布期間 グリーン回復まで 10/27〜 この方法により、2カ月後には、 14グリーン/18ホール 2サブグリーン 2パッテイング・グリーン が顕著な回復 3カ月後には、 2グリーン/18ホール が顕著な回復 2グリーン/18ホール が回復中であった。 次いで、グリーン上の土壌中のBacillus sp の密度を調
査した。グリーン表面より15mm深さの位置より土壌
サンプルを採取し、希釈培養してその密度を調査した結
果、108 個/g/2ホール、107 個/g/12ホー
ル、106 個/g/2ホール、104 個/g/2ホー
ル、107 個/g/Sub2、Pat2 であった。Ba
cillus sp 密度が104 個/gの2ホールのみ、回復が
遅れ気味であったが、更に散布を継続することにより、
回復するものと推察された。また、表面土壌中のBacill
us sp 密度とグリーン芝の回復状態は、顕著な相関が認
められ、除草剤分解が進行したことは、明白となった。
また、シャーレテストにおいても、除草剤分解が実証さ
れた。
Example 10 Decomposition of Pesticide Residue and Recovery of Ground Strength Recently, at a golf course, a herbicide was erroneously sprayed, and a green turf was devastated and became irrecoverable. Therefore, a solution of the same concentration of the herbicide sprayed on the green was obtained, and the herbicide in this solution was replaced with Baci.
After confirming and testing the possibility of decomposition by llus sp and confirming the possibility, the following remedies were taken. Water containing trace amounts of Bacillus sp spores and their metabolites was periodically sprayed on the green to decompose the herbicide remaining in the green. Frequency of spraying Spray every 3 days Spray volume 100 liters / 1 are Spraying period Until the green recovery 10 / 27- By this method, 14 green / 18 holes 2 sub greens 2 putting greens remarkable recovery after 2 months 3 months Later, 2 greens / 18 holes were remarkably recovered. 2 greens / 18 holes were recovering. Next, the density of Bacillus sp in soil on the green was investigated. A soil sample was collected from a position 15 mm deep from the green surface, diluted and cultured, and the density thereof was examined. As a result, 10 8 / g / 2 holes, 10 7 / g / 12 holes, 10 6 / g / g 2 holes, 10 4 pieces / g / 2 holes, 10 7 pieces / g / Sub2, Pat2. Ba
cillus sp Only 2 holes with a density of 10 4 / g seemed to be delayed in recovery, but by continuing spraying,
It was presumed to recover. Also, Bacill in surface soil
A remarkable correlation was found between the us sp density and the recovery status of the green grass, and it became clear that the herbicide decomposition had progressed.
A petri dish test also demonstrated herbicide degradation.

【0036】(実施例 11 茶葉の自然栽培)Bacill
us sp またはその代謝物を、茶樹や茶葉、圃場に供与す
ることにより無農薬乃至減農薬栽培が可能か否かまたそ
の場合の収穫量への影響があるか等について調査した。 実験A 従来慣行農法(化学農薬散布) 実験B Bacillus sp 優占化堆肥の施肥 実験C B水準+希釈分泌液の散布 の各水準を下記の
要領で実施した。 尚、Bacillus sp はその胞子化に際して、特定の病原菌
や病原虫、一般害虫に対しする分泌物を放出するが、そ
の濃度はBacillus sp が高密度胞子集団となればなるほ
ど高くなる。そこで、本実施例では、Bacillus sp の代
謝物を0.01〜0.03ppm の範囲で含有する希釈水を作
成して散布水としたり、Bacillus sp 1010個/g以上
を含有する堆肥を製造して圃場に散布した。
Example 11 Natural Cultivation of Tea Leaves Bacill
It was investigated whether or not pesticide-free or reduced-pesticide cultivation is possible by providing us sp or its metabolite to tea plants, tea leaves, and fields, and whether or not there is an effect on yield. Experiment A Conventional conventional farming (spraying of chemical pesticides) Experiment B Fertilization of Bacillus sp dominated compost Experiment CB Each level of CB level + diluted secretion solution spraying was carried out in the following manner. In addition, Bacillus sp releases secretions to specific pathogens, pathogens and general pests upon sporulation, but the concentration increases as Bacillus sp becomes a high-density spore population. Therefore, in this example, dilution water containing the metabolites of Bacillus sp in the range of 0.01 to 0.03 ppm was prepared and used as spray water, or compost containing Bacillus sp 10 10 cells / g or more was produced. And sprayed on the field.

【0037】(土壌及び葉面散布用・希釈代謝物の作
成)Bacillus sp 胞子1011個/gの密度で保有する菌
種材を、121℃の滅菌箱内に60分間保持してBacill
us sp 以外の雑菌を滅菌し、100倍の正常水中に溶解
し、10分間静かに攪拌して代謝物を溶出し、静置して
菌種材を沈降させ、その上澄水を原液として、葉面散布
用は100倍希釈水、土壌散布用は200倍希釈水とし
て用いた。 (Bacillus sp 堆肥と希釈水散布の実績) 月日 堆肥散布 希釈代謝液散布(L/10a) 備考性 容積Kg/10a 土壌散布 茶葉散布 10/20 〜E 1000 1000 1000 1/16 〜E 3000 2000 *1000 *温暖日に 1/E *1000 散布 2/C *1000 3/R〜E 1000×3回 4/R〜E 1000 1000×2回 5/E 1000 摘茶後散布 合 計 4000 4000 10000 上記の要領で散布した結果、次に示すような効果が得ら
れた 収量(kg/a) 増減比 新芽枚数/30g 備考 実験A 701 1.0 165 一般堆肥+農薬 実験B 960 1.37 129 1010個/g 実験C 1080 1.54 110 原液20L +100L
(Preparation of Dilute Metabolites for Spraying on Soil and Foliage) Bacillus sp. Seed material having a density of 10 11 spores / g was kept in a sterilization box at 121 ° C. for 60 minutes, and Bacillus sp.
Bacteria other than us sp are sterilized, dissolved in 100-fold normal water, gently stirred for 10 minutes to elute metabolites, allowed to stand to sediment the seed material, and the supernatant water is used as a stock solution to give leaves. A 100-fold dilution water was used for surface application and a 200-fold dilution water for soil application. (Achievement of Bacillus sp compost and dilution water spraying) Date Compost spraying Dilute metabolite spraying (L / 10a) Remarks Volume Kg / 10a Soil spraying Tea leaf spraying 10/20 ~ E 1000 1000 1000 1/16 ~ E 3000 2000 * 1000 * On warm days 1 / E * 1000 Spray 2 / C * 1000 3 / R to E 1000 x 3 times 4 / R to E 1000 1000 x 2 times 5 / E 1000 Spray after tea picking Total 4000 4000 10000 Above The following effects were obtained as a result of spraying in the following manner. Yield (kg / a) Increase / decrease ratio Number of sprout / 30 g Remarks Experiment A 701 1.0 165 General compost + pesticide Experiment B 960 1.37 129 10 10 / G Experiment C 1080 1.54 110 Stock solution 20L + 100L

【0038】このように、他の農作物と同様に大きな増
収穫となったが、特徴的なのは、茶葉の肉厚が厚く収穫
重量を押し上げていた。B水準、C水準とも無農薬栽培
であったが、病気や害虫の発生はなかった。Bacillus s
p 堆肥には、Bacillus sp とその代謝分泌物を含有する
ばかりでなく、植物の成長にかかせないN−P−Kのみ
でなく、ケイ酸−Mg−Ca−Fe党の必要なミネラル
を摂取されやすい形で適量を含有し、肥料効果を出現す
るとともに病原性微生物の繁殖を抑制する。さらに、直
接散布した希釈代謝液は、病原菌や病原虫に直接毒性を
発揮してこれらを抑制又は殲滅する効果があり、その結
果の増収穫であった。また、菌種材中には、Bacillus s
p のうちBacillus pumilus等に比較して形状も大きく、
主として澱粉、糖質、セルロース等を分解するBacillus
Thuringiensisは分泌量も多く、更に、それらの菌株の
内で澱粉を1日で分解するような分解速度の速い菌株が
多く存在することが望ましい。
As described above, the yield increased as in the case of other agricultural products, but the characteristic feature was that the thickness of the tea leaves was thick and the yield was increased. Both B and C levels were pesticide-free cultivation, but no disease or pests were found. Bacillus s
p Compost not only contains Bacillus sp and its metabolic secretions, but also consumes the necessary minerals of the silicate-Mg-Ca-Fe party as well as the N-P-K, which is essential for plant growth. It contains an appropriate amount in a form that is easy to be used, and has a fertilizer effect and suppresses the propagation of pathogenic microorganisms. Furthermore, the dilute metabolite directly sprayed has an effect of directly exerting toxicity on pathogenic bacteria and pathogens to suppress or eliminate them, resulting in increased harvest. Bacillus s
The shape of p is larger than Bacillus pumilus, etc.
Bacillus, which mainly degrades starch, sugars, cellulose, etc.
It is desirable that Thuringiensis has a high secretion amount, and that among these strains, there are many strains having a high degradation rate such that starch is degraded in one day.

【0039】[0039]

【発明の効果】以上詳述したように、本発明はBacillus
sp の胞子の発芽、増殖、解体、胞子化と言う増殖サイ
クルを繰り返して、Bacillus sp 密度とともに胞子化に
伴い分泌されるBacillus sp 代謝物や生成物質の濃度を
増加させるものいである。従って、高濃度のBacillus s
p 代謝物や生成物質を容易に得ることができる。そのた
め、家畜や家禽、魚介類の餌に加えるBacillus sp 代謝
物や生成物質の量が従来の100分の1以下になり、食
味を損なわないので採餌率もよく優れた効果を発揮する
などの効果がある。また、人の免疫活性向上や皮膚障害
の治療にも優れた効果を発揮するとともに、植物に成長
や残留農薬の除去など多くの面で利用できる特徴があ
る。
As described in detail above, the present invention relates to Bacillus
By repeating the growth cycle of sp spore germination, proliferation, demolition, and sporulation, it increases the concentration of Bacillus sp metabolites and product secreted with sporulation as well as Bacillus sp density. Therefore, high concentrations of Bacillus s
p Metabolites and products can be easily obtained. As a result, the amount of Bacillus sp metabolites and product substances added to livestock, poultry, and fish and shellfish feeds is less than one-hundredth of conventional levels, and the taste is not impaired. effective. In addition, it has an excellent effect on improving human immune activity and treating skin disorders, and has characteristics that it can be used in many aspects such as growth of plants and removal of residual pesticides.

【0040】更に、貧栄養条件下で増殖サイクルを繰り
返すことにより、Bacillus sp 密度を自然分布密度以下
にまで低下でき、その結果、Bacillus sp 胞子や細胞壁
(ペプチドグリカンや蛋白質)を全く含まず、しかも薬
剤効果がさらに優れたポリペプチドや環状ペプチド等代
謝物や生成物質をえることができる。
Furthermore, by repeating the growth cycle under oligotrophic conditions, the density of Bacillus sp can be reduced below the natural distribution density. As a result, Bacillus sp spores and cell walls (peptidoglycan and protein) are not contained at all, and It is possible to obtain a metabolite or a product such as a polypeptide or a cyclic peptide which is more effective.

【図面の簡単な説明】[Brief description of the drawings]

【図1】ウイルス感染稚海老の消耗率推移を表すグラフ
である。
BRIEF DESCRIPTION OF DRAWINGS FIG. 1 is a graph showing a change in consumption rate of virus-infected juvenile shrimp.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成10年11月16日(1998.11.
16)
[Submission date] November 16, 1998 (1998.11.
16)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0018[Correction target item name] 0018

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0018】Bacillus sp密度は平面培地に
よる希釈培養法により定量し、Bacillus sp
代謝物や生成物質濃度の測定は、代表サンプル10.0
gを秤量分取し、純水500mlを加えて超音波槽(5
0Kz)で3分間溶出させた後、ニュークリポアフイル
ター又はGF−Fフイルター(0.7μm)で吸引濾過
し、105℃の恒温槽内に恒量として秤量して、溶出前
後の重量差により代謝物・生成物質量を求めた。結果
は、以下の通りである。 脱水乾燥汚泥 Bacillus sp密度 12×10個/g (比較材) 代謝物% 0.12% 色 黒色 一次発酵処理 Bacillus sp密度 16×10個/g 代謝物% 1.34% 色 灰色 二次発酵処理 Bacillus sp密度 8×1011個/g 代謝物% 2.44% 色 白色 (加水すると代謝物が溶解して黒色になる) 三次発酵処理 Bacillus sp密度 5×10個/g 代謝物% 8.03% 消化発酵処理 Bacillus sp密度 7×10個/g 代謝物% 11.36% 処理を重ねると代謝物濃度は更に高くなる。このよう
に、比較材(脱水乾燥汚泥)に比較して、Bacill
us sp密度、代謝物濃度共に処理の進行に連れて上
昇している。Bacillus sp密度は限界が予測
される(1011〜1012個/g程度)ものの、代謝
物濃度については、更なる上昇を図ることができる。ま
た、目的により、その密度を減じたり、無菌化とともに
発酵残渣や細胞壁片等を除去して、ポリペプチドや環状
ペプチド等、代謝物や生成物質による人間や動植物の防
疫、伝染疾病の治療、免疫の向上、抗ストレス作用の
向上等の目的を達するものである。従って、高密度Ba
cillus sp及び高濃度Bacillus sp
代謝物を直接利用してその目的を達する範囲も広くな
り、また代謝物を工業的に抽出する場合の基礎工程、素
材としても、極めて有効なものである。尚、代謝物含有
材の製造については、本実施例に限定されるものではな
い。
The Bacillus sp density was determined by a dilution culture method using a flat medium, and the Bacillus sp density was determined.
Measurement of metabolites and product concentrations is based on a representative sample 10.0
g of pure water, 500 ml of pure water was added thereto, and an ultrasonic bath (5
0 Kz) for 3 minutes, then suction-filtered with a Nuclepore filter or GF-F filter (0.7 μm), weighed as a constant weight in a thermostat at 105 ° C. The amount of product was determined. The results are as follows. Dehydrated and dried sludge Bacillus sp density 12 × 10 8 / g (comparative material) Metabolite% 0.12% Color Black Primary fermentation treatment Bacillus sp density 16 × 10 9 / g Metabolite% 1.34% Color Gray Secondary Fermentation treatment Bacillus sp density 8 × 10 11 / g metabolite% 2.44% Color White (metabolite dissolves and becomes black when hydrated) Tertiary fermentation treatment Bacillus sp density 5 × 10 6 / g metabolite% 8.03% digestive fermentation treatment Bacillus sp density 7 × 10 3 cells / g Metabolite% 11.36% Repeated treatment increases the metabolite concentration. Thus, compared to the comparative material (dewatered and dried sludge), Bacill
Both the us sp density and the metabolite concentration increase with the progress of the treatment. Although the Bacillus sp density is expected to have a limit (approximately 10 11 to 10 12 cells / g), the metabolite concentration can be further increased. In addition, depending on the purpose, reduce its density, remove fermentation residues and cell wall fragments with sterilization, and prevent epidemics of humans and animals and plants with metabolites and products such as polypeptides and cyclic peptides, treat infectious diseases, It achieves the objectives of improving immunity and anti-stress effect. Therefore, high density Ba
Cillus sp and high concentration Bacillus sp
The range of achieving the purpose by directly using the metabolites is widened, and it is also extremely effective as a basic process and a raw material for industrially extracting metabolites. The production of the metabolite-containing material is not limited to this example.

【手続補正2】[Procedure amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0019[Correction target item name] 0019

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0019】(ポリペプチドや環状ペプチド等、代謝物
や生成物質濃度の推移)本発明の薬剤製造工程の初期、
中期、終末期、完結期におけるポリペプチドや環状ペプ
チド等、代謝物や生成物質が、それぞれの発酵残渣中に
含有されている。このポリペプチドや環状ペプチド等、
代謝物や生成物質含有量の推移を調査するため、一次工
程終了、二次工程終了、三次工程終了、消化発酵工程終
了、の各時点でサンプリングを行い、それぞれ、10g
を秤量分取し、これに希エタノール(1:3)50ml
を加えて超音波(50kHx、10分)溶解する。次い
で、GF−F(0.7μm)で濾過洗浄して、発酵残渣
を取り除き、溶解液とGF−Fを通過するBacill
us sp胞子及び細胞壁を得る。この混合液を、それ
ぞれスライドガラス上に0.1mlの2点を採取し、ク
リーン・ベンチ内で常温乾燥して溶出物質を析出させ
る。この析出物質を顕微鏡により観察した。また、他の
1点には、無菌水1滴を滴下して析出物を溶解し、顕微
鏡観察した。その結果、
(Changes in Concentrations of Metabolites and Produced Substances such as Polypeptides and Cyclic Peptides) At the beginning of the drug production process of the present invention,
Metabolites and product substances such as polypeptides and cyclic peptides in the middle stage, terminal stage, and final stage are contained in each fermentation residue. Such as polypeptides and cyclic peptides,
In order to investigate changes in metabolites and product content, sampling was performed at each time point of the end of the primary process, the end of the secondary process, the end of the tertiary process, and the end of the digestive fermentation process, and 10 g each
Weighed and weighed, and diluted ethanol (1: 3) 50 ml
And ultrasonically dissolve (50 kHz × 10 minutes). Then, it was filtered and washed with GF-F (0.7 μm) to remove fermentation residues, and the lysate and Bacill passing through GF-F were used.
Obtain us sp spores and cell wall. Two points each of 0.1 ml of this mixed solution are collected on a slide glass, and dried at room temperature in a clean bench to precipitate an eluted substance. This deposited substance was observed with a microscope. At one other point, one drop of sterile water was dropped to dissolve the precipitate, and observed under a microscope. as a result,

【手続補正3】[Procedure amendment 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0027[Correction target item name] 0027

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0027】(実施例 6 豚の防疫)平均体重12K
gの子豚10頭×2実験区と、10頭の対照区を用意
し、各実験区には本発明のポリペプチドや環状ペプチド
等代謝物や生成物質よりなる薬剤(消化発酵処理→遠心
分離)を混入した飼料を投与し、対照区には、薬剤を混
入しない餌を投与し、60日間飼育した。実験区におけ
る薬剤混入水準は、実験1区では体重1kg当たり0.
5mg、実験2区では同じく1.0mgである。 No.代謝物等水準 類型発病数 備考 実験1区 0.5mg 0 実験2区 1.0mg 0 対照区 0mg 6 抗生物質投与 この結果、実験区では何らの病気も発生しなかったが、
対照区では腸ビブルス菌による下痢が発生した。これ
は、本発明のポリペプチドや環状ペプチド等代謝物や生
成物質よりなる薬剤が、子豚の免疫向上や伝染性疾病の
予防に効果があることを示す。
Example 6 Protection of Pigs Average Weight 12K
g piglets × 10 experimental pigs and 10 control pigs were prepared, and in each experimental plot, a drug (digestion / fermentation → centrifugation) consisting of a metabolite or product such as the polypeptide or cyclic peptide of the present invention was prepared. ) Was administered, and a control group was administered a diet containing no drug, and bred for 60 days. The level of drug incorporation in the experimental plot was 0.1 kg / kg body weight in the experimental plot.
5 mg, and 1.0 mg in the second experiment. No. Level of metabolites, etc. Type of incidence Remarks Experiment 1 section 0.5 mg 0 Experiment 2 section 1.0 mg 0 Control section 0 mg 6 Antibiotic administration As a result, no disease occurred in the experimental section,
In the control group, diarrhea caused by intestinal vibrios occurred. This indicates that a drug comprising a metabolite or a product such as the polypeptide or cyclic peptide of the present invention is effective for improving immunity of piglets and preventing infectious diseases.

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0035[Correction target item name] 0035

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0035】(実施例 10 残留農薬の分解と地力回
復)最近、あるゴルフ場において、間違って除草剤を散
布し、グリーンの芝が壊滅的な打撃を受け、回復不可能
な状態になった。そこで、グリーンに散布された除草剤
の同一濃度の溶液を入手し、この溶液申の除草剤をBa
cillus spによって分解できないかを確認テス
トし、その可能性を確認できたので、以下の方法で救済
処置をとった。Bacillus sp胞子及びその代
謝物を微量に含有する水を定期的にグリーンに散布して
グリーンに残留する除草剤を分解することとした。 散布する頻度 3日毎に散布 散布量 100リットル/1アール 散布期間 グリーン回復まで 10/27〜 この方法により、2カ月後には、 14グリーン/18ホール 2サブグリーン 2パッテイング・グリーンが顕著な回復 3カ月後には、 2グリーン/18ホール が顕著な回復 2グリーン/18ホール が回復中であった。 次いで、グリーン上の土壌中のBacillus sp
の密度を調査した。グリーン表面より15mm深さの位
置より土壌サンプルを採取し、希釈培養してその密度を
調査した結果、10個/g/2ホール、10個/g
/12ホール、10個/g/2ホール、10個/g
/2ホール、10個/g/Sub2、Pat2 であ
った。Bacillus sp密度が10個/gの2
ホールのみ、回復が遅れ気味であったが、更に散布を継
続することにより、回復するものと推察された。また、
表面土壌中のBacillus sp密度とグリーン芝
の回復状態は、顕著な相関が認められ、除草剤分解が進
行したことは、明白となった。また、シャーレテストに
おいても、除草剤分解が実証された。
Example 10 Decomposition of Pesticide Residue and Recovery of Ground Strength Recently, at a golf course, a herbicide was erroneously sprayed, and a green turf was devastated and became irrecoverable. Therefore, a solution of the same concentration of the herbicide sprayed on the green was obtained, and this herbicide was applied to Ba.
A confirmation test was performed to determine whether or not it could be degraded by C. sp., and the possibility was confirmed. Therefore, rescue treatment was performed by the following method. Water containing trace amounts of Bacillus sp spores and their metabolites was periodically sprayed on the green to decompose the herbicide remaining in the green. Frequency of spraying Spray every 3 days Spray volume 100 liters / 1 are Spraying period Until green recovery October 27- By this method, 14 green / 18 holes 2 sub greens 2 putting greens remarkable recovery after 2 months 3 months Later, 2 greens / 18 holes were remarkably recovered. 2 greens / 18 holes were recovering. Then Bacillus sp in soil on green
Was investigated for density. A soil sample was taken from a position 15 mm deep from the green surface, diluted and cultured, and the density thereof was examined. As a result, 10 8 pieces / g / 2 holes, 10 7 pieces / g
/ 12 holes, 10 6 / g / 2 holes, 10 4 / g
/ 2 hole was 10 7 / g / Sub2, pat2. Bacillus sp density of 10 4 / g 2
The recovery was likely to be delayed only in the hole, but it was assumed that the recovery would be continued by continuing spraying. Also,
A remarkable correlation was observed between the Bacillus sp density in the surface soil and the recovery status of the green turf, and it became clear that the herbicide decomposition had progressed. A petri dish test also demonstrated herbicide degradation.

【手続補正5】[Procedure amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0037[Correction target item name] 0037

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0037】(土壌及び葉面散布用・希釈代謝物の作
成)Bacillus sp胞子1011個/gの密度
で保有する菌種材を、121℃の滅菌箱内に60分間保
持してBacillus sp以外の雑菌を滅菌し、1
00倍の正常水中に溶解し、10分間静かに攪拌して代
謝物を溶出し、静置して菌種材を沈降させ、その上澄水
を原液として、葉面散布用は100倍希釈水、土壌散布
用は200倍希釈水として用いた。 (Bacillus sp堆肥と希釈水散布の実績) 月日 堆肥散布 希釈代謝液散布(L/10a) 備考性 容積Kg/10a 土壌散布 茶葉散布 10/20〜E 1000 1000 1000 1/16〜E 3000 2000 *1000 (*温暖日に散布) 1/E *1000 2/C *1000 3/R〜E 1000×3回 4/R〜E 1000 1000×2回 5/E 1000 (摘茶後散布) 合 計 4000 4000 10000 上記の要領で散布した結果、次に示すような効果が得ら
れた 収量 増減比 新芽枚数 備考 (kg/a) (/30g) 実験A 701 1.0 165 一般堆肥+農薬 実験B 960 1.37 129 1010個/g 実験C 1080 1.54 110 原液20L+100L
(Preparation of Dilute Metabolites for Soil and Foliar Spraying) Bacillus sp spores were kept at a density of 10 11 spores / g in a sterilization box at 121 ° C. for 60 minutes, except for Bacillus sp. Sterilize various bacteria
Dissolve in 00-fold normal water, gently stir for 10 minutes to elute metabolites, allow to stand to sediment the bacterial seed material, and use the supernatant water as a stock solution, 100-fold diluted water for foliar spraying, For soil application, 200 times dilution water was used. (Results of Bacillus sp compost and dilution water spraying) Date Compost spreading Dilute metabolite spraying (L / 10a) Remarks Volume Kg / 10a Soil spraying Tea leaf spraying 10/20 to E 1000 1000 1000 1/16 to E 3000 2000 * 1000 (* sprayed on warm days) 1 / E * 1000 2 / C * 1000 3 / R to E 1000 × 3 times 4 / R to E 1000 1000 × 2 times 5 / E 1000 (sprayed after tea removal) Total 4000 4000 10000 The following effects were obtained as a result of spraying as described above. Yield Increase / decrease ratio Number of sprout Remarks (kg / a) (/ 30g) Experiment A 701 1.0 165 General compost + pesticide Experiment B 960 1 .37 129 10 10 / g Experiment C 1080 1.54 110 Stock solution 20L + 100L

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/74 ABE A61K 35/74 ABE 4D004 ABG ABG 4D027 ADA ADA B09C 1/10 ZAB C02F 3/00 C02F 3/00 C12P 1/04 Z C12P 1/04 B09B 3/00 ZABE //(C12N 1/00 C12R 1:07) Fターム(参考) 2B104 EF09 2B150 AC02 4B064 AH19 CA02 CC04 CC05 CD23 DA01 DA11 DA16 4B065 AA15X BA22 BC41 BC50 BD02 CA43 CA44 CA50 CA56 4C087 AA01 AA02 AA03 AA10 BC64 CA08 CA10 MA01 MA16 MA63 NA14 ZA89 ZA90 ZB02 ZB09 ZB13 ZB15 ZB32 ZB33 ZC61 ZC65 4D004 AA41 AB10 BA10 CA18 CC02 CC07 CC08 4D027 CA03 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 35/74 ABE A61K 35/74 ABE 4D004 ABG ABG 4D027 ADA ADA B09C 1/10 ZAB C02F 3/00 C02F 3 / 00 C12P 1/04 Z C12P 1/04 B09B 3/00 ZABE // (C12N 1/00 C12R 1:07) F term (reference) 2B104 EF09 2B150 AC02 4B064 AH19 CA02 CC04 CC05 CD23 DA01 DA11 DA16 4B065 AA15X BA22 BC41 BC50 BD02 CA43 CA44 CA50 CA56 4C087 AA01 AA02 AA03 AA10 BC64 CA08 CA10 MA01 MA16 MA63 NA14 ZA89 ZA90 ZB02 ZB09 ZB13 ZB15 ZB32 ZB33 ZC61 ZC65 4D004 AA41 AB10 BA10 CA18 CC02 CC07 CC08 4D027 CA03

Claims (14)

【特許請求の範囲】[Claims] 【請求項1】 Bacillus sp の胞子の発芽、増殖、解
体、胞子化と言う増殖サイクルを繰り返して、菌体の活
動や胞子化に伴い分泌されるBacillus sp 代謝物や生成
物質の濃度を増加させることを特徴とする高密度Bacill
us sp 及び高濃度Bacillus sp 代謝物含有材の製造方法
The present invention increases the concentration of metabolites and metabolites of Bacillus sp, which are secreted with the activity and sporulation of bacterial cells, by repeating the growth cycle of germination, growth, demolition and sporulation of spores of Bacillus sp. High density Bacill
Method for producing material containing metabolites of us sp and high concentration Bacillus sp
【請求項2】 排水処理施設や培養槽等の水系でBacill
us sp を増殖して、汚泥等の沈殿物中のBacillus sp 胞
子濃度が108 個/g程度になった時点で沈殿物を採取
し、固液分離した脱水沈殿物を更に乾燥し、これに栄養
分や酸素、熱を与えて発酵させる発酵工程を繰り返すこ
とにより、Bacillus sp 胞子密度とともに代謝物や生成
物質濃度を増加させるものである、請求項1記載の高密
度Bacillus sp 及び高濃度Bacillus sp 代謝物含有材の
製造方法
2. Bacill is used in water systems such as wastewater treatment facilities and culture tanks.
When the concentration of Bacillus sp spores in the sediment such as sludge reaches about 10 8 / g, the sediment is collected, and the solid-liquid separated dehydrated sediment is further dried. The high-density Bacillus sp and the high-concentration Bacillus sp metabolism according to claim 1, wherein the fermentation step of fermenting by applying nutrients, oxygen, and heat is repeated to increase the concentration of metabolites and produced substances as well as the density of Bacillus sp spores. Method of manufacturing material containing material
【請求項3】Bacillus sp の胞子の発芽、増殖、解体、
胞子化と言う増殖サイクルを繰り返して得た高濃度Baci
llus sp 及び高濃度Bacillus sp 代謝物含有材につい
て、更に、貧栄養条件下で増殖サイクルを繰り返すこと
により、Bacillus sp 密度を自然分布密度である104
個/g以下にまで低下させるとともに、Bacillus sp 細
胞壁を消滅させ、さらにBacillus sp 代謝物や生成物質
濃度を上昇させるものである、高濃度Bacillus sp 代謝
物含有材の製造方法。
3. Spore germination, proliferation, disassembly of Bacillus sp.
High concentration Baci obtained by repeating the growth cycle called sporulation
For the llus sp and the high-concentration Bacillus sp metabolite-containing material, the growth cycle was further repeated under oligotrophic conditions to reduce the Bacillus sp density to the natural distribution density of 10 4
A method for producing a material containing a high-concentration Bacillus sp metabolite, which is intended to reduce the Bacillus sp cell wall and to increase the concentration of a Bacillus sp metabolite and a produced substance while reducing the number of Bacillus sp cell walls to not more than the number per cell / g.
【請求項4】 Bacillus sp の胞子の発芽、増殖、解
体、胞子化と言う増殖サイクルを繰り返して、菌体の活
動や胞子化に伴い分泌されるBacillus sp 代謝物や生成
物質の濃度を増加させたことを特徴とする高密度Bacill
us sp 及び高濃度Bacillus sp 代謝物含有材。
4. The germination, proliferation, demolition, and sporulation of spores of Bacillus sp are repeated to increase the concentration of metabolites and product of Bacillus sp secreted with the activity of cells and sporulation. High-density Bacill
Us sp and high concentration Bacillus sp metabolite containing material.
【請求項5】Bacillus sp の胞子の発芽、増殖、解体、
胞子化と言う増殖サイクルを繰り返し、更に貧栄養条件
下で増殖サイクルを繰り返して、Bacillus sp の低密度
胞子化と代謝物や生成物質の高濃度化を図ったことを特
徴とする低密度Bacillus sp 及び高濃度Bacillus sp 代
謝物含有材。
5. Spore germination, growth, disintegration of Bacillus sp.
A low-density Bacillus sp. Characterized by repeating a growth cycle called sporulation and further repeating a growth cycle under oligotrophic conditions to achieve low-density sporulation of Bacillus sp and high concentration of metabolites and produced substances. And high concentration Bacillus sp metabolite-containing material.
【請求項6】 請求項4又は請求項5記載のBacillus s
p 代謝物含有材から、溶媒を用いてポリペプチドや環状
ペプチド等の代謝物や生成物質を溶出させ、該溶液をそ
のまま或いは更に遠心分離や濾過によって胞子や発酵残
渣等を除去した液状薬剤。
6. The Bacillus s according to claim 4 or claim 5.
p A liquid drug in which a metabolite or product such as a polypeptide or a cyclic peptide is eluted from a metabolite-containing material using a solvent, and the solution is removed as it is or by further centrifugation or filtration to remove spores and fermentation residues.
【請求項7】 請求項4又は請求項5記載のBacillus s
p 代謝物含有材から、溶媒を用いてポリペプチドや環状
ペプチド等の代謝物や生成物質を溶出させ、該溶液をそ
のまま或いは更に遠心分離や濾過によって胞子や発酵残
渣等を除去したのち、溶媒を蒸発させた粉状薬剤。
7. Bacillus s according to claim 4 or claim 5.
From the metabolite-containing material, a solvent is used to elute metabolites and product substances such as polypeptides and cyclic peptides using a solvent, and the solution is used as it is, or after spores and fermentation residues are removed by centrifugation or filtration, the solvent is removed. Evaporated powdered drug.
【請求項8】 請求項4又は請求項5記載の代謝物含有
材或いは請求項6又は請求項7記載の薬剤を、直接又は
飼料や飲料水に混入して、家畜や家禽、魚介類やその他
の動植物に与えることにより、防疫や伝染性疾病の治
療、抗ウイルス免疫の向上、抗ストレス作用を発現させ
るための方法。
8. The livestock, poultry, fish and shellfish and the like, wherein the metabolite-containing material according to claim 4 or 5 or the drug according to claim 6 or 7 is mixed directly or in feed or drinking water. For preventing epidemics and treating infectious diseases, improving antiviral immunity, and expressing an antistress effect by giving the composition to animals and plants.
【請求項9】 請求項4又は請求項5記載の代謝物含有
材或いは請求項6又は請求項7記載の薬剤を主成分とす
る免疫活性賦活剤。
9. An immunostimulant comprising the metabolite-containing material according to claim 4 or 5 or the drug according to claim 6 or 7 as a main component.
【請求項10】 請求項4又は請求項5記載の代謝物含
有材或いは請求項6又は請求項7記載の薬剤を主成分と
するNK活性賦活剤。
10. An NK activity activator comprising the metabolite-containing material according to claim 4 or 5 or the drug according to claim 6 or 7 as a main component.
【請求項11】 請求項4又は請求項5記載の代謝物含
有材或いは請求項6又は請求項7記載の薬剤を主成分と
するリュウマチ治療剤。
11. A therapeutic agent for rheumatism containing the metabolite-containing material according to claim 4 or 5 or the drug according to claim 6 or 7 as a main component.
【請求項12】 請求項6又は請求項7記載の薬剤を主
成分とする水虫、虫刺され、アトピー性皮膚炎の治療
剤。
12. A therapeutic agent for athlete's foot, insect bites, and atopic dermatitis, comprising the agent according to claim 6 or 7 as a main component.
【請求項13】請求項6の液状薬剤或いは請求項7の粉
状薬剤を蒸留水に溶解したものを主成分とし、これにエ
チルアルコールとグリセリンを添加溶解したことを特徴
とする化粧品。
13. A cosmetic product comprising, as a main component, a solution obtained by dissolving the liquid drug according to claim 6 or the powder drug according to claim 7 in distilled water, to which ethyl alcohol and glycerin are added and dissolved.
【請求項14】 Bacillus sp を106 個/g以上含有
する土壌や、106個/ml以上のBacillus sp 及び0.
01ppm 以上のBacillus sp 代謝物や生成物質を含有す
る水を用いて、Bacillus sp が栄養として残留農薬を分
解し、その毒性を排除することを特徴とする土壌浄化方
法。
14. A soil containing at least 10 6 / g of Bacillus sp, a Bacillus sp of at least 10 6 / ml and 0.1% of Bacillus sp.
A soil purification method characterized in that Bacillus sp decomposes pesticide residues as nutrients using water containing Bacillus sp metabolites and product substances of not less than 01 ppm and eliminates its toxicity.
JP24916098A 1997-08-18 1998-08-18 Method for producing Bacillussp metabolite-containing material Expired - Fee Related JP3768694B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24916098A JP3768694B2 (en) 1997-08-18 1998-08-18 Method for producing Bacillussp metabolite-containing material

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP23765797 1997-08-18
JP9-237657 1998-07-25
JP10-225362 1998-07-25
JP22536298 1998-07-25
JP24916098A JP3768694B2 (en) 1997-08-18 1998-08-18 Method for producing Bacillussp metabolite-containing material

Publications (2)

Publication Number Publication Date
JP2000102378A true JP2000102378A (en) 2000-04-11
JP3768694B2 JP3768694B2 (en) 2006-04-19

Family

ID=27331038

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24916098A Expired - Fee Related JP3768694B2 (en) 1997-08-18 1998-08-18 Method for producing Bacillussp metabolite-containing material

Country Status (1)

Country Link
JP (1) JP3768694B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006111573A (en) * 2004-10-14 2006-04-27 Ee H C:Kk Use of bacillus subtilis sp. and food containing the same to be used
JP2007291057A (en) * 2006-03-29 2007-11-08 Idemitsu Kosan Co Ltd Harmful bacteria-controlling agent for human containing bacillus thuringiensis
JP2007537270A (en) * 2004-05-11 2007-12-20 ガネデン バイオテック インコーポレイテッド Methods and compositions for dietary management of autoimmune disorders
WO2011096567A1 (en) * 2010-02-05 2011-08-11 有限会社メイショウ Method for degrading organic material using mother cell lyases formed in association with spore formation of microorganism
JP5557967B1 (en) * 2013-03-13 2014-07-23 株式会社シティック Method for producing seeding agent
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
CN109482618A (en) * 2015-12-01 2019-03-19 北京德瑞丰农业科技有限责任公司 The purposes of bacillus M2 degradation agricultural wastes
CN109761710A (en) * 2019-03-26 2019-05-17 江西联普人农业发展有限公司 A kind of organic fertilizer of degradable pesticide residue and its application
CN110743264A (en) * 2019-11-16 2020-02-04 杭州昕华信息科技有限公司 Spore-imitating drum-packed filter plate for filtering gas suspended matters
CN113215052A (en) * 2021-05-27 2021-08-06 江苏盛立环保工程有限公司 Application of bacillus in industrial sludge reduction and attenuation
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
JP2007537270A (en) * 2004-05-11 2007-12-20 ガネデン バイオテック インコーポレイテッド Methods and compositions for dietary management of autoimmune disorders
US8409591B2 (en) 2004-05-11 2013-04-02 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
JP2006111573A (en) * 2004-10-14 2006-04-27 Ee H C:Kk Use of bacillus subtilis sp. and food containing the same to be used
JP2007291057A (en) * 2006-03-29 2007-11-08 Idemitsu Kosan Co Ltd Harmful bacteria-controlling agent for human containing bacillus thuringiensis
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US9757442B2 (en) 2009-04-29 2017-09-12 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
JP5308542B2 (en) * 2010-02-05 2013-10-09 有限会社メイショウ Degradation method of organic matter using mother cell degrading enzyme accompanying spore formation of microorganisms
AU2011211640B2 (en) * 2010-02-05 2015-08-13 Meisho.Co.,Ltd Method for degrading organic material using mother cell lyases formed in association with spore formation of microorganism
WO2011096567A1 (en) * 2010-02-05 2011-08-11 有限会社メイショウ Method for degrading organic material using mother cell lyases formed in association with spore formation of microorganism
US9102957B2 (en) 2010-02-05 2015-08-11 Meisho Co., Ltd. Method for degrading organic material using mother cell lyases formed in association with spore formation of microorganism
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US11351206B2 (en) 2011-03-31 2022-06-07 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
WO2014141406A1 (en) * 2013-03-13 2014-09-18 株式会社シティック Method for producing seeding agent
JP5557967B1 (en) * 2013-03-13 2014-07-23 株式会社シティック Method for producing seeding agent
CN109482618A (en) * 2015-12-01 2019-03-19 北京德瑞丰农业科技有限责任公司 The purposes of bacillus M2 degradation agricultural wastes
CN109761710A (en) * 2019-03-26 2019-05-17 江西联普人农业发展有限公司 A kind of organic fertilizer of degradable pesticide residue and its application
CN110743264B (en) * 2019-11-16 2021-08-17 林丽兵 Spore-imitating drum-packed filter plate for filtering gas suspended matters
CN110743264A (en) * 2019-11-16 2020-02-04 杭州昕华信息科技有限公司 Spore-imitating drum-packed filter plate for filtering gas suspended matters
CN113215052B (en) * 2021-05-27 2022-01-04 江苏盛立环保工程有限公司 Application of bacillus in industrial sludge reduction and attenuation
CN113215052A (en) * 2021-05-27 2021-08-06 江苏盛立环保工程有限公司 Application of bacillus in industrial sludge reduction and attenuation

Also Published As

Publication number Publication date
JP3768694B2 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
WO2017069479A1 (en) Method of manufacturing organic fertilizers by using organic raw material, antagonistic microorganism, fermentative microorganism, and synthetic microorganism, and organic fertilizers manufactured by said manufacturing method
CN106754510B (en) Bacillus subtilis, preparation and application thereof
CN106800466A (en) Ecological rice field composite microbiological fertilizer and preparation method thereof
JP2019519206A (en) Nutrients Comprising Antioxidant Water, and Methods of Producing Water Supply for Plant Cultivation, Animal Breeding or Fish Culture with the Nutrients
JP3768694B2 (en) Method for producing Bacillussp metabolite-containing material
CN107266183A (en) Chicken manure organic fertilizer and preparation method thereof
Jain et al. Microbiological and enzymatic properties of diverse Jaivik Krishi inputs used in organic farming
CN109485512A (en) Dual-purpose soil structure conditioner of a kind of medicine fertilizer and preparation method thereof
WO2007059583A1 (en) Fertilizer and soil ameliorant
CN106305510B (en) Pond aquaculture method
JP3533466B2 (en) How to treat shochu lees
CN1227969C (en) Water quality modifier for aquaculture made from bagasse, and mfg. method and use thereof
CN101708187B (en) Dry powder preparation for preventing and controlling saprolegniasis of aquatic animals and preparation method thereof
KR102132065B1 (en) Antagonistic microorganism, fermentative microorganism, synthetic microorganism, method by organic raw material and organic fertilizers produced of manufacturing the same
CN105876133A (en) Feed additive for aquatic organisms and preparation method thereof
CN107412322B (en) Composition for preventing and treating aquaculture saprolegniasis and preparation method thereof
CN105995224A (en) Preparation method of multifunctional aquaculture water body improver
JP4052535B2 (en) Animal drugs and animal feed
CN105441358B (en) Bacillus licheniformis preparation and its application for the fermentation of aquatic farm scene
CN111944733B (en) Corynebacterium glutamicum and application thereof
JP7401072B2 (en) Microalgae growth promoter and its manufacturing method
CN113678962A (en) Micro-ecological feed additive for aquaculture and use method thereof
CN109220924B (en) Shrimp, crab and fish polyculture method
CN106982739A (en) A kind of microbial degradation bedding and padding
CN111909868A (en) Composite microbial inoculum for preventing and treating anorexia dead fish of grass carps as well as preparation method and application thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050812

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051221

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060202

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100210

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110210

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120210

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120210

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130210

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130210

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees